Gerresheimer AG

GXI

Equity

ISIN DE000A0LD6E6 / Valor 3138496

Xetra (2024-12-23)

EUR 70.00+3.47%

Gerresheimer AG
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

Gerresheimer AG is a global leader in pharmaceutical packaging and drug delivery devices, offering a wide range of products such as insulin pens, inhalers, prefillable syringes, and packaging for the cosmetics industry. With a focus on providing safe, reliable, and convenient solutions for the administration of medicines, Gerresheimer serves as a go-to partner for pharmaceutical, health, well-being, and biotech companies worldwide. With around 12,000 employees and 35 plants globally, the company is dedicated to meeting the needs of its customers and their end-users by delivering innovative products from concept to final production.

Summarized from source with an LLMView SourceSector: Industrials

Revenue Growth

In the second quarter of 2024, Gerresheimer AG reported revenues of EUR 502.4 million, a slight increase from EUR 499.6 million in the same quarter of the previous year. For the first half of 2024, revenues reached EUR 968.5 million, up from EUR 957.4 million in the first half of 2023, reflecting a 1.2% growth.

Adjusted EBITDA

Gerresheimer AG's adjusted EBITDA for Q2 2024 was EUR 107.3 million, nearly unchanged from EUR 107.2 million in Q2 2023. For the first six months of 2024, adjusted EBITDA increased to EUR 188.2 million from EUR 185.2 million in the same period of the previous year, marking a 1.6% rise.

Earnings Per Share

In Q2 2024, Gerresheimer AG's earnings per share (EPS) were EUR 0.94, down from EUR 1.05 in Q2 2023, a decrease of 10.5%. For the first half of 2024, EPS dropped to EUR 1.32 from EUR 1.45 in the first half of 2023, representing a 9.0% decline.

Cash Flow

Gerresheimer AG experienced a significant reduction in cash flow from operating activities, which fell to EUR 8.0 million in Q2 2024 from EUR 35.2 million in Q2 2023, a decrease of 77.3%. For the first half of 2024, cash flow from operating activities was EUR 35.2 million, compared to a negative EUR 13.9 million in the same period of the previous year.

Net Financial Debt

As of May 31, 2024, Gerresheimer AG's net financial debt stood at EUR 1,097.2 million, an increase of 18.7% from EUR 924.3 million as of November 30, 2023. This rise in debt is partly attributed to the company's recent acquisition activities and capital expenditures.

Summarized from source with an LLMView Source

Key figures

-26.5%1Y

-16.0%3Y

0.43%5Y

Performance

41.1%1Y

39.4%3Y

35.6%5Y

Volatility